Changchun BCHT Biotechnology Co.

Quick facts

Marketed products

• Herpes Zoster Vaccine, Live · Immunology / Infectious Disease
  This live attenuated vaccine stimulates the immune system to recognize and respond to varicella-zoster virus, preventing herpes zoster (shingles) reactivation.

Phase 3 pipeline

• DTacP · Oncology
  DTacP is a diphtheria toxin-based immunotoxin that targets and eliminates cells expressing specific tumor-associated antigens.
• DTacP-IPV/Hib · Immunology / Infectious Disease Prevention
  DTacP-IPV/Hib is a combination vaccine that provides immunization against diphtheria, tetanus, acellular pertussis, poliomyelitis, and Haemophilus influenzae type b through inactivated antigens and toxoids.
• live attenuated zoster vaccine · Immunology
  The live attenuated zoster vaccine works by introducing a weakened form of the varicella-zoster virus to stimulate an immune response.

Phase 1 pipeline

• approved influenza vaccine
• influenza vaccine（BK01 adjuvnat）
• Mid-Dose Cohort

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Changchun BCHT Biotechnology Co. portfolio CI brief
• Changchun BCHT Biotechnology Co. pipeline updates RSS